INVA CIK: 1080014

Innoviva, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
392
FY22:
318
FY23:
246
FY24:
296
FY25:
308
(positive)
Change from FY21 to FY25
millions USD
FY21:
375
FY22:
207
FY23:
114
FY24:
167
FY25:
164
(positive)
Change from FY21 to FY22
millions USD
FY21:
458
FY22:
53.8
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
445
FY22:
287
FY23:
194
FY24:
37.4
FY25:
327
(positive)
Change from FY21 to FY24
millions USD
FY21:
266
FY22:
214
FY23:
180
FY24:
23.4
FY25:
–

All amounts in millions USD Data sources:SEC EDGARTwelve Data